Simplex Trading’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-900
| Closed | -$1K | – | 10260 |
|
|
2023
Q3 | $1K | Buy |
+900
| New | +$786 | ﹤0.01% | 8492 |
|
|
2022
Q3 | – | Sell |
-6,000
| Closed | -$6K | – | 11225 |
|
|
2022
Q2 | $6K | Sell |
6,000
-4,300
| -42% | -$5.48K | ﹤0.01% | 8772 |
|
|
2022
Q1 | $21K | Sell |
10,300
-300
| -3% | -$713 | ﹤0.01% | 8229 |
|
|
2021
Q4 | $30K | Sell |
10,600
-3,500
| -25% | -$12.9K | ﹤0.01% | 7917 |
|
|
2021
Q3 | $75K | Hold |
14,100
| – | – | ﹤0.01% | 7023 |
|
|
2021
Q2 | $74K | Buy |
+14,100
| New | +$67.8K | ﹤0.01% | 7158 |
|
|
2021
Q1 | – | Sell |
-162
| Closed | -$53K | – | 10353 |
|
|
2020
Q4 | $53K | Buy |
162
+7
| +5% | +$27 | ﹤0.01% | 6123 |
|
|
2020
Q3 | $51K | Sell |
155
-1,589
| -91% | -$5.84K | ﹤0.01% | 5593 |
|
|
2020
Q2 | $587K | Buy |
1,744
+1,725
| +9,079% | +$8.16K | ﹤0.01% | 2713 |
|
|
2020
Q1 | $7K | Sell |
19
-291
| -94% | -$1.35K | ﹤0.01% | 6709 |
|
|
2019
Q4 | $187K | Sell |
310
-237
| -43% | -$1.62K | ﹤0.01% | 3844 |
|
|
2019
Q3 | $413K | Buy |
547
+441
| +416% | +$4.97K | ﹤0.01% | 2809 |
|
|
2019
Q2 | $143K | Sell |
106
-34
| -24% | -$393 | ﹤0.01% | 3823 |
|
|
2019
Q1 | $75K | Buy |
140
+110
| +367% | +$535 | ﹤0.01% | 4638 |
|
|
2018
Q4 | $8K | Sell |
30
-83
| -73% | -$454 | ﹤0.01% | 6008 |
|
|
2018
Q3 | $92K | Buy |
113
+91
| +414% | +$698 | ﹤0.01% | 4517 |
|
|
2018
Q2 | $21K | Sell |
22
-11
| -33% | -$113 | ﹤0.01% | 5833 |
|
|
2018
Q1 | $13K | Sell |
33
-164
| -83% | -$1.77K | ﹤0.01% | 3819 |
|
|
2017
Q4 | $7K | Sell |
197
-19
| -9% | -$218 | ﹤0.01% | 4246 |
|
|
2017
Q3 | $12K | Buy |
216
+101
| +88% | +$1.07K | ﹤0.01% | 3634 |
|
|
2017
Q2 | $39K | Sell |
115
-196
| -63% | -$3.9K | ﹤0.01% | 2629 |
|
|
2017
Q1 | $101K | Buy |
311
+300
| +2,727% | +$5.96K | ﹤0.01% | 1751 |
|
|
2016
Q4 | $1K | Buy |
+11
| New | +$148 | ﹤0.01% | 5577 |
|
Simplex Trading's ZYNE Position: Q2 2023 in Review
Simplex Trading sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q2 2023, closing a stake of 2,274 shares — an estimated $815 sold.
Simplex Trading first reported a position in ZYNE in Q4 2016 and held it in 13 quarters. The position peaked at $467K in Q1 2017. 41 funds tracked by Wall St. Rank hold ZYNE as of Q2 2023.
- Simplex Trading reported no remaining Zynerba Pharmaceuticals, Inc position as of Q2 2023 after selling out during the quarter.
- Simplex Trading sold 2,274 Zynerba Pharmaceuticals, Inc shares in Q2 2023, an estimated $815.
- Simplex Trading first reported a position in Zynerba Pharmaceuticals, Inc in Q4 2016 and held it in 13 quarters.
- Simplex Trading's Zynerba Pharmaceuticals, Inc position peaked at $467K in Q1 2017.
- 41 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q2 2023.
Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.